The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
✍ Scribed by Hichame Id Boufker; Laurence Lagneaux; Mehdi Najar; Martine Piccart; Ghanem Ghanem; Jean-Jacques Body; Fabrice Journé
- Book ID
- 115010073
- Publisher
- BioMed Central
- Year
- 2010
- Tongue
- English
- Weight
- 813 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1471-2407
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Osteogenic cells differentiated from bone marrow‐derived mesenchymal stromal cells (MSC) hold much promise in bone tissue engineering and reconstructive surgery. There is a dire need for well‐defined and efficient protocols to promote the osteogenesis of __ex vivo__ cultured MSC. Hence,
## Abstract Association of osteoprogenitor cells to calcium phosphate ceramics is currently under intense investigation, for its considered ability to induce bone formation and therefore to allow the successful repair of large bone defects. However, if the first experimental and clinical studies pr